-
The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Patients with Itch-Dominant Moderate-to-Severe Atopic Dermatitis Treated in Private Dermatology Facilities in the United States
Mar 10, 2025, 14:00 PM -
Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
Gender-Based Gaps In Access to Tricuspid Valve Interventions In England
Mar 10, 2025, 14:00 PM -
Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review
Mar 10, 2025, 14:00 PM -
Real-World Evaluation of Trastuzumab Deruxtecan Administration, Compliance, and Dose Utilization in Chinese Patients With HER2-Positive Advanced Breast Cancer
Mar 10, 2025, 14:00 PM -
Glucocorticoid Exposure and the Risk of Serious Infections in CIDP
Mar 10, 2025, 14:00 PM -
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims
Mar 10, 2025, 14:00 PM -
State of Evidence on Cost-Effectiveness Analysis of Health Technologies in Colombia: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Exploring the Relationship Between Hemoglobin Levels and Clinical Outcomes in Anemic Dialysis-Dependent Chronic Kidney Disease Patients
Mar 10, 2025, 14:00 PM -
Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA
Mar 10, 2025, 14:00 PM -
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Structured Evaluation of Oncology Real-World Data Quality for Practical Applications
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Olanzapine for Cancer Cachexia Management
Mar 10, 2025, 14:00 PM -
Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Quality-of-Life Outcomes of Radioligand Therapy Used in Combination with Systemic Therapies for Neuroendocrine Tumors: A Systematic Review
Mar 10, 2025, 14:00 PM
